Hesperetin ameliorates lipopolysaccharide‐induced acute lung injury via the miR‐410/SOX18 axis
Authors:
- 6 August 2020
- journal article
- research article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 34 (12) , e22588
Abstract
Hesperetin (Hesp), a dihydroflavone, has a wide range of pharmacological activities, including antioxidant, anti‐inflammatory, and antitumor effects, as well as cardiovascular protection. It also has protective effects against acute lung injury (ALI); however, the exact mechanism remains unclear. In the present study, the protective effects and mechanism of Hesp in the lungs were investigated. Hematoxylin and eosin staining was used to examine pathological changes in the lungs. Enzyme‐linked immunosorbent assay was used to detect proinflammatory cytokine levels. In addition, reverse transcription‐quantitative polymerase chain reaction and Western blot analysis were used to observe the transcription and translation changes in the related genes, respectively. The results indicate that Hesp not only improves histopathological changes in the lungs but decreases the wet/dry ratio. In addition, total cell counts and the number of neutrophils and macrophages were lower in the bronchoalveolar fluid after Hesp treatment, consistent with the change in proinflammatory cytokine levels. MicroRNA‐410 (miR‐410) levels were significantly lower in the lung tissues of ALI mice and were reversed after Hesp treatment. Furthermore, miR‐410 overexpression due to injection with agomiR‐410 produced similar protective effects as Hesp. However, blocking miR‐410 inhibited the protective effects of Hesp in the lungs of ALI mice. In addition, miR‐410 has been shown to target the inhibition of sex determining region Y‐box 18 (SOX18), indicating that Hesp might alleviate inflammatory secretion by blocking the miR‐410/SOX18 axis. Thus, Hesp might be a potential agent for the treatment of ALI.Keywords
This publication has 20 references indexed in Scilit:
- LPS-induced Acute Lung Injury Involves NF-κB–mediated Downregulation of SOX18American Journal of Respiratory Cell and Molecular Biology, 2018
- MicroRNAJournal of Allergy and Clinical Immunology, 2018
- miR‐34b‐5p inhibition attenuates lung inflammation and apoptosis in an LPS‐induced acute lung injury mouse model by targeting progranulinJournal of Cellular Physiology, 2018
- Functional role and therapeutic targeting of microRNAs in inflammatory bowel diseaseAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2018
- MicroRNAs as biomarkers of acute lung injuryAnnals of Translational Medicine, 2018
- MicroRNAs in mucosal inflammationJournal of Molecular Medicine, 2017
- Lobeline improves acute lung injury via nuclear factor-κB-signaling pathway and oxidative stressRespiratory Physiology & Neurobiology, 2016
- Hesperetin attenuates ventilator-induced acute lung injury through inhibition of NF-κB-mediated inflammationEuropean Journal of Pharmacology, 2015
- Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental ModelsPhytotherapy Research, 2014
- Hesperetin protects against oxidative stress related hepatic dysfunction by cadmium in ratsExperimental and Toxicologic Pathology, 2012